Saturday, April 01, 2017 2:02:05 PM
1. I am a new consumer of Premier Biomedical CBD patch. I used several CBD products and found this one is best one.
2. According to trend, they will sell product to China and India finally. Do you guys know how many people in these two counties have pain issue? there is more than 200M. if 10% of people buy our patch/oil, everyone buy 10 patch per year and 5 dollar profit per patch. Our Profit should be 1B dollar.
3. Premier Biomedical has several cancer patents, one is already approved and another one is rejected Oct 2016 (we already know last year). But if other companies want to use our one patent, that's extra income. Actually we all focus on Nice CBD patch/oil. Several patents that Premier Biomedical has licensed (three issued patients, one European PCT, and approximately ten pending ... (anyone really care one of them?)
4. I watched some videos about Premier Biomedical and confidence for my future investment.
5. I do my own DD and found Premier Biomedical never did RS and history is extremely good. Not like other OTC for several RS history. This is true credit.
5. I talked with Hartman due to my package price issue. he is a honest and true man.
5. You should know 95% OTC companies have 0 revenue and 0 products. We have great products and revenue.
5. I very like our current Share structure now. 447-122 = 325M and 90% shares are locked. Our floating is very low.
It's just my personal opinion. Good luck buddies.
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM